https://www.endocrine.org/journals/journal-of-the-endocrine-society/pth-decreases-sclerostin-in-hyperparathyroidism
PTH Decreases Sclerostin in Hyperparathyroidism | Endocrine Society
To elucidate whether decreased sclerostin levels affect increased fibroblast growth factor 23 (FGF23) levels in parathyroid hormone (PHPT), we sought to...
pthdecreasessclerostinhyperparathyroidismendocrine
https://www.deutsche-digitale-bibliothek.de/item/K7XFUGPDIERQB554JF22WDXW2SJJ2ED3
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism...
antisclerostininternalizationmediatedantagonism
https://www.jci.org/articles/view/167811
JCI - Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21...
https://www.mdpi.com/2077-0383/11/3/806
The Role of Sclerostin in Bone Diseases
Sclerostin has been identified as an important regulator of bone homeostasis through inhibition of the canonical Wnt-signaling pathway, and it is involved in...
the rolesclerostinbonediseases
https://pmc.ncbi.nlm.nih.gov/articles/PMC11142749/
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes -...
Trisomy 21 (T21), a recurrent aneuploidy occurring in 1:800 births, predisposes to congenital heart disease (CHD) and multiple extracardiac phenotypes. Despite...
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1472680/full
Frontiers | Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with...
IntroductionAcromegaly is a disease characterized by enhanced bone turnover with persistently high vertebral fracture risk. Sclerostin is a glycoprotein, whi...
https://www.biospace.com/transcenta-announces-nmpa-acceptance-of-ind-application-of-its-anti-sclerostin-monoclonal-antibody-tst002
Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody...
Jul 6, 2021 - Transcenta Holding Limited today announces that NMPA has accepted IND application of its anti-sclerostin monoclonal antibody TST002.
ind application
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00159/full
Frontiers | Sclerostin Antibody Mitigates Estrogen Deficiency-Inducted Marrow Lipid Accumulation...
Sclerostin knock-out mice or sclerostin antibody (Scl-Ab) treated wild-type mice displayed decreased marrow adiposity. But the effects of Scl-Ab on estrogen ...
estrogen deficiencyfrontierssclerostinantibodymitigates